Initial Management of New Edema in Congestive Heart Failure

Assessment and Diagnosis

• The American Heart Association recommends evaluating the patient for volume status, adequacy of systemic perfusion, precipitating factors, and whether the heart failure is new onset or an exacerbation of chronic disease 4
• The American College of Cardiology suggests obtaining diagnostic tests, including chest radiograph, ECG, echocardiography, and B-type natriuretic peptide (BNP) or NT-proBNP levels, to assess cardiac function and identify potential causes of heart failure 4, 1

Initial Pharmacologic Management

• The European Society of Cardiology recommends starting IV loop diuretics without delay in the emergency department for patients with significant fluid overload, with an initial dose of 20-40 mg IV furosemide (or equivalent) for diuretic-naïve patients 1
• The American Heart Association suggests that the initial IV dose for patients already on chronic diuretic therapy should equal or exceed their chronic oral daily dose, and that diuretic therapy can be administered as either intermittent boluses or continuous infusion 4, 2, 1

Monitoring and Adjustments

• The American College of Cardiology recommends monitoring response to diuretic therapy by measuring fluid intake and output, daily weight measurements, and daily serum electrolytes, urea nitrogen, and creatinine 2, 3, 4
• The European Society of Cardiology suggests intensifying the diuretic regimen using higher doses of loop diuretics, or adding a second diuretic, if diuresis is inadequate 5, 4, 2

Additional Supportive Measures

• The American Heart Association recommends administering oxygen therapy if hypoxemia is present, and maintaining guideline-directed medical therapy (GDMT) for chronic heart failure unless hemodynamic instability or contraindications exist 4, 2

Special Considerations

• The American College of Cardiology suggests considering inotropic or vasopressor support for patients with hypotension and hypoperfusion with elevated cardiac filling pressures, and ultrafiltration for patients with refractory congestion 4, 2
• The European Society of Cardiology recommends evaluating for other causes of edema if it persists despite adequate diuretic therapy 3, 6

Common Pitfalls and Caveats

• The American Heart Association warns against excessive diuresis leading to volume contraction, and recommends caution with NSAIDs and COX-2 inhibitors as they can worsen heart failure and increase risk of hospitalization 5, 1
• The European Society of Cardiology advises against using thiazolidinediones (glitazones) in heart failure patients as they increase the risk of fluid retention and heart failure exacerbation 1